i
Laboratory clinical sample collection and storage guidance for e-cigarette, or vaping, product use-associated lung injury (EVALI)
-
04/07/2020
Details:
-
Corporate Authors:
-
Description:CDC encourages clinicians to report possible cases of e-cigarette, or vaping, product-use-associated lung injury (EVALI), to their local or state health department for further investigation. If use of e-cigarette,
or vaping, products is suspected as a possible cause for a patient’s symptoms, a detailed history of the substances used, the devices used, and the sources of the substances and devices, should be obtained, as outlined in Update:Interim Guidance for Health Care Providers Evaluating and Caring for Patients with Suspected E-cigarette, or Vaping, Product Use Associated Lung Injury — United States, October 2019.
The below outlines general guidance regarding collection and storage of clinical samples. This may include retention of residual clinical samples collected for patient care, or samples collected and stored from early in a patient’s presentation to look for markers of exposure.
Healthcare providers and state public health authorities should work together to make decisions about the collection and storage of clinical samples. Healthcare providers should initiate communication promptly with their local or state public health laboratory to retain samples if further analysis is anticipated.
Publication date from document properties.
Lab-Clinical-Specimen-Collection-Storage-Guidance-Lung-Injury-508.pdf
-
Subjects:
-
Document Type:
-
Genre:
-
Collection(s):
-
Main Document Checksum:
-
Download URL:
-
File Type: